SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-20-017682
Filing Date
2020-08-12
Accepted
2020-08-12 17:12:37
Documents
62
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q kmph20200630_10q.htm 10-Q 1803354
2 EXHIBIT 31.1 ex_192365.htm EX-31.1 14663
3 EXHIBIT 31.2 ex_192366.htm EX-31.2 14746
4 EXHIBIT 32.1 ex_192367.htm EX-32.1 7199
5 EXHIBIT 32.2 ex_192368.htm EX-32.2 7459
  Complete submission text file 0001437749-20-017682.txt   7012205

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT kmph-20200630.xml EX-101.INS 1421330
7 XBRL TAXONOMY EXTENSION SCHEMA kmph-20200630.xsd EX-101.SCH 63790
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE kmph-20200630_cal.xml EX-101.CAL 36206
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE kmph-20200630_def.xml EX-101.DEF 423558
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE kmph-20200630_lab.xml EX-101.LAB 360450
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE kmph-20200630_pre.xml EX-101.PRE 448727
Mailing Address 1180 CELEBRATION BOULEVARD, SUITE 103 CELEBRATION FL 34747
Business Address 1180 CELEBRATION BOULEVARD, SUITE 103 CELEBRATION FL 34747 (321) 939-3416
KEMPHARM, INC (Filer) CIK: 0001434647 (see all company filings)

IRS No.: 205894398 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36913 | Film No.: 201096185
SIC: 2834 Pharmaceutical Preparations